Clinical Trial Update: Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula [NA]

View source ↗

Summary

A completed clinical trial evaluating the hypoallergenicity of a new extensively hydrolyzed formula for cow's milk allergy, conducted by Nestlé SPN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Allergy

Drugs mentioned

• Extensively Hydrolyzed Formula (Nestlé SPN) (extensively hydrolyzed formula)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Cow Milk Allergy | NA | Status: COMPLETED